Health officials warn that prolonged use of nasal decongestant sprays like Vicks, Sudafed, and Otrivine can lead to rebound congestion and addiction. Users are advised to limit use to five days to avoid dependency and potential long-term health issues.
British health authorities are issuing a critical warning regarding the prolonged use of over-the-counter nasal decongestant sprays, commonly used to alleviate congestion caused by allergies and colds.
Sprays containing xylometazoline and oxymetazoline, sold under popular brands like Vicks, Sudafed, and Otrivine, offer temporary relief by shrinking swollen nasal passages. However, the Medicines and Healthcare products Regulatory Agency (MHRA) cautions that using these sprays for more than five consecutive days can lead to a dependency known as rebound congestion, or rhinitis medicamentosa. This occurs when the nasal tissues become reliant on the medication to function normally, resulting in worsened congestion and a cycle of increasing spray usage.
The MHRA highlights that rebound congestion can manifest as persistent irritation, a runny nose, sneezing, and continued blockage, ultimately requiring increased doses of the spray to achieve the same effect. In severe cases, chronic swelling can lead to breathing difficulties and even facial disfigurement, potentially necessitating surgical intervention. The agency is now actively urging consumers to adhere to the five-day usage limit and is planning to update product packaging and leaflets to reflect this guidance.
Experts emphasize that while these sprays are safe when used correctly, exceeding the recommended duration can create a problematic addiction. Professor Amira Guirguis of the Royal College of Pharmacy supports clearer product information and public messaging to raise awareness about the short-term nature of these treatments.
Recent studies indicate a significant lack of awareness among the public, with nearly 60% of pharmacists believing patients are unaware of the long-term risks, and over 20% of adults admitting to using the sprays for longer than a week. The issue has been brought to light through personal stories like that of Charlotte Johnstone, a 30-year-old who has battled a 23-year addiction to nasal decongestant sprays, starting at the age of seven.
Her experience illustrates the psychological and physical toll of prolonged use, including anxiety, sleep disturbances, and a diminished sense of smell. While most individuals can successfully discontinue use without lasting damage, some may require steroid-based treatments to manage withdrawal symptoms. The MHRA’s warning follows similar concerns raised by the Royal Pharmaceutical Society, and some advocate for prescription-only access to these medications to better control their distribution and prevent overuse.
The agency stresses the importance of consulting a healthcare professional if congestion persists beyond five days, suggesting it may be a sign of overuse rather than the original ailment. They also remind users to carefully read the Patient Information Leaflet accompanying the medication
Nasal Decongestant Addiction Rebound Congestion MHRA Rhinitis Medicamentosa Xylometazoline Oxymetazoline Health Warning
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
It’s hard to avoid obstacles that we ourselves create in addiction recovery.While there are many externally imposed obstacles early in recovery, some of the biggest come from within us.
Read more »
Map Reveals States With The Worst Drug Addiction ProblemsNew Mexico tops the list for the state with the worst drug problems, according to new analysis.
Read more »
Child safety risk sparks popular nasal spray recall, nearly 800K bottles impactedBayer issued a recall of nearly 800,000 travel-size Afrin nasal spray bottles after finding packaging not child resistant, CPSC announced.
Read more »
Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' NosesNasal spray flu vaccines appear to work differently from traditional jabs, creating a battlefield in the nose for invading viruses, a new study says.
Read more »
Warning Issued Over Nasal Decongestant Spray Addiction RiskThe MHRA advises Britons to limit the use of nasal decongestant sprays to five days to avoid dependency and rebound congestion, a condition that can lead to chronic swelling and breathing difficulties. The warning follows concerns about widespread overuse and calls for clearer labeling and prescription controls.
Read more »
Nasal Decongestant Spray Addiction Risk: Five-Day Limit UrgedHealth officials warn against prolonged use of nasal decongestant sprays like Vicks, Sudafed, and Otrivine, citing the risk of rebound congestion and addiction. Users are advised to limit use to five days to avoid dependence and potential long-term health issues.
Read more »